Wednesday, Dec 5, 2012 8:55 PM UTC
Obamacare architect heads to Big Pharma
Liz Fowler again exemplifies the blurred lines between the healthcare industry and Washington
Topics:
Liz Fowler, Johnson & Johnson, Obamacare, Affordable Care Act, Public Option, healthcare, Big Pharma



